VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 27 filers reported holding VASCULAR BIOGENICS LTD in Q2 2017. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2018 | $2,000 | -71.4% | 1,000 | 0.0% | 0.00% | -100.0% |
Q4 2017 | $7,000 | +16.7% | 1,000 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $6,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2017 | $4,000 | -33.3% | 1,000 | 0.0% | 0.00% | -100.0% |
Q1 2017 | $6,000 | +20.0% | 1,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $5,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Spectrum Planning & Advisory Services Inc. | 16,000 | $2,681 | 0.00% |
Virtu Financial LLC | 37,424 | $6 | 0.00% |
Affinity Capital Advisors, LLC | 22,265 | $3,729 | 0.00% |
MORGAN STANLEY | 409,011 | $68,509 | 0.00% |
HBK Sorce Advisory LLC | 20,575 | $3,447 | 0.00% |
Bank of New York Mellon Corp | 39,000 | $6,533 | 0.00% |
Harel Insurance Investments & Financial Services Ltd. | 11,000 | $2 | 0.00% |
SIMPLEX TRADING, LLC | 100 | $0 | 0.00% |
Tower Research Capital LLC (TRC) | 937 | $0 | 0.00% |
ROYAL BANK OF CANADA | 798 | $0 | 0.00% |